Medical Mycology

Papers
(The H4-Index of Medical Mycology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches84
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19)62
Update onCandida krusei, a potential multidrug-resistant pathogen55
On the lineage of Aspergillus fumigatus isolates in common laboratory use53
CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris47
General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation29
Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds27
COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City25
NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile24
Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification24
Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group23
Ebselen and diphenyl diselenide against fungal pathogens: A systematic review22
Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center22
High detection rate of azole-resistantAspergillus fumigatusafter treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low 21
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan20
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients20
Filamentous growth is a general feature of Candida auris clinical isolates19
Emerging and future strategies in the management of recalcitrant Candida auris19
Deep fungal infections diagnosed by histology in Uganda: a 70-year retrospective study19
0.05876898765564